Junwei Shi
Impact in
- Molecular Biology top 0.5%
- Protein Degradation and Inhibitors
- Genomics and Chromatin Dynamics
- CRISPR and Genetic Engineering
- Epigenetics and DNA Methylation
- RNA modifications and cancer
- Chromatin Remodeling and Cancer
- Hematology top 1%
- Acute Myeloid Leukemia Research
Papers in
- Genetics 15
- Hemoglobinopathies and Related Disorders 14
- Hematology 15
- Acute Myeloid Leukemia Research 15
- Co-authors
- Christopher R. Vakoc (21 shared papers)Eric Wang (7 shared papers)Joseph P. Milazzo (4 shared papers)Scott Lowe (5 shared papers)Justin B. Kinney (4 shared papers)Johannes A. Zuber (4 shared papers)James E. Bradner (4 shared papers)Jun Qi (4 shared papers)
- Journals
- Blood (12 papers)Molecular Cell (7 papers)Nature Communications (5 papers)Nature Biotechnology (4 papers)Cell (4 papers)
- Partner nations
- United StatesChinaAustria
In The Last Decade
Junwei Shi
91 papers receiving 10.8k citations
Junwei Shi's Hit Papers
Peers
Comparison fields: 5 of 107
- Molecular Biology 6.9k
- Hematology 1.1k
- Oncology 1.4k
- Genetics 518
- Cancer Research 523
Countries citing papers authored by Junwei Shi
This map shows the geographic impact of Junwei Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junwei Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junwei Shi more than expected).
Fields of papers citing papers by Junwei Shi
This network shows the impact of papers produced by Junwei Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junwei Shi. The network helps show where Junwei Shi may publish in the future.
Co-authors
The 25 scholars most cited alongside Junwei Shi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 95 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc Hit paper breakdown → | 2011 | 2419 |
| 2 | RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia Hit paper breakdown → | 2011 | 1587 |
| 3 | Promoter-bound METTL3 maintains myeloid leukaemia by m6A-dependent translation control Hit paper breakdown → | 2017 | 901 |
| 4 | The Mechanisms behind the Therapeutic Activity of BET Bromodomain Inhibition Hit paper breakdown → | 2014 | 748 |
| 5 | Discovery of cancer drug targets by CRISPR-Cas9 screening of protein domains Hit paper breakdown → | 2015 | 587 |
| 6 | Roles of arabidopsis WRKY18, WRKY40 and WRKY60 transcription factors in plant responses to abscisic acid and abiotic stress Hit paper breakdown → | 2010 | 458 |
| 7 | 2013 | 281 | |
| 8 | 2018 | 278 | |
| 9 | 2018 | 174 | |
| 10 | 2021 | 156 | |
| 11 | 2016 | 155 | |
| 12 | 2021 | 149 | |
| 13 | 2012 | 135 | |
| 14 | 2019 | 133 | |
| 15 | 2018 | 129 | |
| 16 | 2016 | 127 | |
| 17 | 2021 | 126 | |
| 18 | 2015 | 121 | |
| 19 | 2018 | 112 | |
| 20 | 2013 | 105 |
About Junwei Shi
Junwei Shi is a scholar working on Genetics, Hematology, Molecular Biology, Oncology and Immunology, having authored 95 papers that have together received 10.9k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (15 papers), Hemoglobinopathies and Related Disorders (14 papers), CRISPR and Genetic Engineering (11 papers), Protein Degradation and Inhibitors (10 papers), Chromatin Remodeling and Cancer (10 papers), Genomics and Chromatin Dynamics (9 papers), Acute Lymphoblastic Leukemia research (6 papers) and Cancer Immunotherapy and Biomarkers (5 papers). The work is most often cited by research in Molecular Biology (6.9k citations), Hematology (1.1k citations), Oncology (1.4k citations), Genetics (518 citations) and Cancer Research (523 citations). Junwei Shi has collaborated with scholars based in United States, China and Austria. Frequent co-authors include Christopher R. Vakoc, Eric Wang, Joseph P. Milazzo, Scott Lowe, Justin B. Kinney, Johannes A. Zuber, James E. Bradner, Jun Qi, Christopher Johns and Amy Rappaport. Their work appears in journals such as Blood, Molecular Cell, Nature Communications, Nature Biotechnology and Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.